Found: 32
Select item for more details and to access through your institution.
Impact of dose adaptations following voriconazole therapeutic drug monitoring in pediatric patients.
- Published in:
- Medical Mycology, 2019, v. 57, n. 8, p. 937, doi. 10.1093/mmy/myz006
- By:
- Publication type:
- Article
Idiopathic infantile arterial calcification: clinical presentation, therapy and long-term follow-up.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Fatigue trajectories during pediatric ALL therapy are associated with fatigue after treatment: a national longitudinal cohort study.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 1, p. 1, doi. 10.1007/s00520-022-07456-x
- By:
- Publication type:
- Article
Pharmacokinetics of PEGasparaginase in Infants with Acute Lymphoblastic Leukemia.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 4, p. 711, doi. 10.1007/s11095-024-03693-3
- By:
- Publication type:
- Article
Severe steroid‐related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy—An observational Ponte di Legno Toxicity Working Group Study.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 4, p. 1450, doi. 10.1111/bjh.19610
- By:
- Publication type:
- Article
Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia?
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 6, p. e82, doi. 10.1111/bjh.18372
- By:
- Publication type:
- Article
Direct X-ray radiogrammetry versus dual-energy X-ray absorptiometry: assessment of bone density in children treated for acute lymphoblastic leukaemia and growth hormone deficiency.
- Published in:
- 2006
- By:
- Publication type:
- journal article
A longitudinal study using tibial ultrasonometry as a bone assessment technique in children with acute lymphoblastic leukaemia.
- Published in:
- Pediatric Radiology, 2003, v. 33, n. 3, p. 162, doi. 10.1007/s00247-002-0814-4
- By:
- Publication type:
- Article
Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 2, p. 506, doi. 10.1210/jcem.87.2.8202
- By:
- Publication type:
- Article
Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12 , 3745.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143510
- By:
- Publication type:
- Article
Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial).
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3745, doi. 10.3390/cancers12123745
- By:
- Publication type:
- Article
Population Pharmacokinetics of Vincristine Related to Infusion Duration and Peripheral Neuropathy in Pediatric Oncology Patients.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1789, doi. 10.3390/cancers12071789
- By:
- Publication type:
- Article
Randomized controlled trial on the effect of 1‐hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis).
- Published in:
- Cancer Medicine, 2023, v. 12, n. 19, p. 19480, doi. 10.1002/cam4.6550
- By:
- Publication type:
- Article
The association between vincristine‐induced peripheral neuropathy and health‐related quality of life in children with cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 22, p. 8172, doi. 10.1002/cam4.4289
- By:
- Publication type:
- Article
Osteoporosis in Childhood: Bone Density of Children in Health and Disease.
- Published in:
- Journal of Pediatric Endocrinology & Metabolism, 2001, v. 14, n. 7, p. 817, doi. 10.1515/jpem.2001.14.7.817
- By:
- Publication type:
- Article
TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Bone density and body composition in chronic renal failure: effects of growth hormone treatment.
- Published in:
- Pediatric Nephrology, 2000, v. 15, n. 3/4, p. 221, doi. 10.1007/s004670000470
- By:
- Publication type:
- Article
Depletion of d- and l-asparagine in cerebrospinal fluid in acute lymphoblastic leukemia during PEGasparaginase therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Parental functioning during maintenance treatment for childhood acute lymphoblastic leukemia: Effects of treatment intensity and dexamethasone pulses.
- Published in:
- Pediatric Blood & Cancer, 2020, v. 67, n. 11, p. 1, doi. 10.1002/pbc.28697
- By:
- Publication type:
- Article
High prevalence of parent-reported sleep problems in pediatric patients with acute lymphoblastic leukemia after induction therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pharmacokinetics and population pharmacokinetics in pediatric oncology.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A cost-effectiveness analysis of Erwinia asparaginase therapy in children with acute lymphoblastic leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ammonia Levels Should Not Be Used as a Surrogate Marker of Levels of Asparaginase Activity in Acute Lymphoblastic Leukemia Patients.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Population Pharmacokinetics of Inotuzumab Ozogamicin in Pediatric Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Results of Study ITCC-059.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 7, p. 981, doi. 10.1007/s40262-024-01386-z
- By:
- Publication type:
- Article
No evidence of increased asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 2, p. 258, doi. 10.1002/pbc.24292
- By:
- Publication type:
- Article
Successful management of extreme hypertriglyceridemia in a child with acute lymphoblastic leukemia by temporarily omitting dexamethasone while continuing asparaginase.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 58, n. 2, p. 317, doi. 10.1002/pbc.23266
- By:
- Publication type:
- Article
Osteoporosis in children with cancer.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 50, p. 474, doi. 10.1002/pbc.21407
- By:
- Publication type:
- Article
No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2006, v. 46, n. 1, p. 88, doi. 10.1002/pbc.20437
- By:
- Publication type:
- Article
Bone mineral density in childhood acute lymphoblastic leukemia (ALL) during and after treatment.
- Published in:
- Pediatric Blood & Cancer, 2004, v. 43, n. 2, p. 182, doi. 10.1002/pbc.20051
- By:
- Publication type:
- Article
A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia.
- Published in:
- Journal of Bone & Mineral Research, 2021, v. 36, n. 12, p. 2290, doi. 10.1002/jbmr.4442
- By:
- Publication type:
- Article